| 臺大學術典藏 |
2021-08-31T06:42:25Z |
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
|
Chen T.W.-W.; Chen H.-M.; Lin C.-H.; Huang C.-S.; ANN-LII CHENG; Lai M.-S.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:42:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; Yeh K.-H.; Lu Y.-S.; ANN-LII CHENG; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; Lin C.-H.; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; ANN-LII CHENG; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-08-31T06:29:50Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:46Z |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Lin C.-H.; Chen I.-C.; Huang C.-S.; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; Chang D.-Y.; Wang M.-Y.; Chang C.-H.; Chen W.-W.; Lu Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:45Z |
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer
|
Chen I.-C.; Chang Y.-C.; Lu Y.-S.; Chung K.-P.; Huang C.-S.; Lu T.-P.; Kuo W.-H.; Wang M.-Y.; Kuo K.-T.; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; Lin C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:44Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen I.-C.; Lin C.-H.; Jan I.-S.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:43Z |
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer
|
Chen B.-B.; Lu Y.-S.; Lin C.-H.; Chen W.-W.; Wu P.-F.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-31T06:29:42Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1�V2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai S.-F.; Chen Y.-H.; Kuo W.-H.; Lien H.-C.; Wang M.-Y.; Lu Y.-S.; Lo C.; Kuo S.-H.; ANN-LII CHENG; Huang C.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:33Z |
Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen
|
Chen I.-C.; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; Lin C.-H.; Wei-Wu Chen T.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:30Z |
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
|
Chen T.W.-W.; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; Chang D.-Y.; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-08-31T06:29:29Z |
Adiposity, inflammation, and breast cancer pathogenesis in Asian Women
|
Iyengar N.M.; Chen I.-C.; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; Lu Y.-S.; Hsueh T.-H.; ANN-LII CHENG; Hudis C.A.; Lin C.-H.; Dannenberg A.J. |
| 臺大學術典藏 |
2021-08-31T06:29:27Z |
Effect of glucocorticoid use on survival in patients with stage I�VIII breast cancer
|
Lin C.-H.; Chuang P.-Y.; You S.-L.; Chiang C.-J.; Huang C.-S.; Wang M.-Y.; Chao M.; Lu Y.-S.; ANN-LII CHENG; Tang C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:25Z |
Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer
|
Chen B.-B.; Lu Y.-S.; Yu C.-W.; Lin C.-H.; Chen T.W.-W.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-31T06:29:21Z |
Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
|
Lin C.-H.; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; Huang C.-S.; ANN-LII CHENG; Lu Y.-S.; Asian Breast Cancer Cooperative Group |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations
|
Chen C.-H.; Lu Y.-S.; ANN-LII CHENG; Huang C.-S.; Kuo W.-H.; Wang M.-Y.; Chao M.; Chen I.-C.; Kuo C.-W.; Lu T.-P.; Lin C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:17Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:15Z |
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women
|
Tsai M.-S.; Chang S.-H.; Kuo W.-H.; Kuo C.-H.; Li S.-Y.; Wang M.-Y.; Chang D.-Y.; Lu Y.-S.; Huang C.-S.; ANN-LII CHENG; Lin C.-H.; Chen P.-C. |
| 臺大學術典藏 |
2021-08-16T03:26:42Z |
Axillary vs sentinel lymph node dissectionfor invasive breast cancer [2]
|
I-CHUN CHEN; Lin C.-H.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-16T03:26:41Z |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
I-CHUN CHEN; Lin C.H.; Huang C.S.; Lien H.C.; Hsu C.; Kuo W.H.; Lu Y.S.; Cheng A.L. |
| 臺大學術典藏 |
2021-08-16T03:26:40Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; I-CHUN CHEN; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-16T03:26:39Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
I-CHUN CHEN; Lin C.-H.; Jan I.-S.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-16T03:26:39Z |
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer
|
I-CHUN CHEN; Chang Y.-C.; Lu Y.-S.; Chung K.-P.; Huang C.-S.; Lu T.-P.; Kuo W.-H.; Wang M.-Y.; Kuo K.-T.; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; Lin C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-16T03:26:38Z |
Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen
|
I-CHUN CHEN; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; Lin C.-H.; Wei-Wu Chen T.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-16T03:26:37Z |
PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study
|
Yang M.-H.; I-CHUN CHEN; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-16T03:26:37Z |
Adiposity, inflammation, and breast cancer pathogenesis in Asian Women
|
Iyengar N.M.; I-CHUN CHEN; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; Lu Y.-S.; Hsueh T.-H.; Cheng A.-L.; Hudis C.A.; Lin C.-H.; Dannenberg A.J. |
| 臺大學術典藏 |
2021-08-16T03:26:36Z |
Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations
|
Chen C.-H.; Lu Y.-S.; Cheng A.-L.; Huang C.-S.; Kuo W.-H.; Wang M.-Y.; Chao M.; I-CHUN CHEN; Kuo C.-W.; Lu T.-P.; Lin C.-H. |
| 臺大學術典藏 |
2021-08-16T03:26:35Z |
Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival
|
Chen T.W.-W.; Jan I.-S.; Chang D.-Y.; Lin C.-H.; I-CHUN CHEN; Chen H.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-16T03:26:32Z |
Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components
|
Lien H.-C.; Lee Y.-H.; I-CHUN CHEN; Lin C.-H.; Chen T.W.-W.; Lu Y.-T.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-16T03:26:30Z |
Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
|
I-CHUN CHEN; Hu F.-C.; Lin C.-H.; Huang S.-M.; Chang D.-Y.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-12T04:01:30Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; YANG SHIH-HUNG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:53Z |
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
|
Lu Y.-S.; Kashida Y.; Kulp S.K.; Wang Y.-C.; Wang D.; Hung J.-H.; Tang M.; ZHONG-ZHE LIN; Chen T.-J.; Cheng A.-L.; Chen C.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:47Z |
The impact of diabetes mellitus on prognosis of early breast cancer in Asia
|
Chen W.-W.; Shao Y.-Y.; Shau W.-Y.; ZHONG-ZHE LIN; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; Cheng A.-L.; Lai M.-S. |
| 臺大學術典藏 |
2021-08-11T03:46:47Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Shao Y.-Y.; ZHONG-ZHE LIN; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-10T03:53:06Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG; Huang S.-M.; Hsu C.; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-05T02:41:59Z |
The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation
|
Lai S.-F;Chen Y.-H;Liang T.H.-K;Hsu C.-Y;Lien H.-C;Lu Y.-S;Huang C.-S;Kuo S.-H.; Lai S.-F; Chen Y.-H; Liang T.H.-K; Hsu C.-Y; Lien H.-C; Lu Y.-S; Huang C.-S; Kuo S.-H.; HSIANG-KUANG LIANG |
| 臺大學術典藏 |
2021-08-05T02:41:31Z |
Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
|
Kuo C.-T;Chen C.-L;Li C.-C;Huang G.-S;Ma W.-Y;Hsu W.-F;Lin C.-H;Lu Y.-S;Wo A.M.; Kuo C.-T; Chen C.-L; Li C.-C; Huang G.-S; Ma W.-Y; Hsu W.-F; Lin C.-H; Lu Y.-S; Wo A.M.; ANDREW WO |
| 臺大學術典藏 |
2021-08-05T02:40:44Z |
Preparation and characterization of cerium-based conversion coating on a Fe50Mn30Co10Cr10 dual-phase high-entropy alloy
|
Chen L.-A;Lu Y.-S;Lin Y.-T;Lee Y.-L.; Chen L.-A; Lu Y.-S; Lin Y.-T; Lee Y.-L.; YUEH-LIEN LEE |
| 臺大學術典藏 |
2021-08-05T02:37:13Z |
Effects of different electrodes used in bone-guided extracochlear implants on electrical stimulation of auditory nerves in guinea pigs
|
Liu C.-H;Lu Y.-S;Chen P.-C;Lee C.-F.; Liu C.-H; Lu Y.-S; Chen P.-C; Lee C.-F.; CHIEN-HAO LIU |
| 臺大學術典藏 |
2021-07-28T06:46:58Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Kuo S.-H.; Lien H.-C.; You S.-L.; Lu Y.-S.; CHING-HUNG LIN; Chen T.-Z.; Huang C.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:57Z |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
|
Huang C.-S.; Kuo S.-H.; Lien H.-C.; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN; Lu Y.-S.; Chang K.-J. |
| 臺大學術典藏 |
2021-07-28T06:46:57Z |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
CHING-HUNG LIN; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-28T06:46:56Z |
Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!
|
Chang D.-Y.; CHING-HUNG LIN; Lu Y.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:55Z |
Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example
|
Huang C.-S.; CHING-HUNG LIN; Lu Y.-S.; Shen C.-Y. |
| 臺大學術典藏 |
2021-07-28T06:46:45Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; CHING-HUNG LIN; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; Cheng A.-L.; Lu Y.-S. |
| 臺大學術典藏 |
2021-07-28T06:46:40Z |
Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma
|
Chiu H.-H.; Tsai I.-L.; Lu Y.-S.; CHING-HUNG LIN; Kuo C.-H. |
| 臺大學術典藏 |
2021-07-28T06:46:39Z |
Effect of glucocorticoid use on survival in patients with stage I–III breast cancer
|
CHING-HUNG LIN; Chuang P.-Y.; You S.-L.; Chiang C.-J.; Huang C.-S.; Wang M.-Y.; Chao M.; Lu Y.-S.; Cheng A.-L.; Tang C.-H. |
| 臺大學術典藏 |
2021-07-28T06:46:37Z |
Treating HR+/HER2? breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression
|
Yeo W.; Ueno T.; CHING-HUNG LIN; Liu Q.; Lee K.-H.; Leung R.; Naito Y.; Park Y.H.; Im S.-A.; Li H.; Yap Y.S.; Lu Y.-S.; The Asian Breast Cancer Cooperative Group |
| 臺大學術典藏 |
2021-07-28T06:46:37Z |
Insights into Breast Cancer in the East vs the West: A review
|
Yap Y.-S.; Lu Y.-S.; Tamura K.; Lee J.E.; Ko E.Y.; Park Y.H.; Cao A.-Y.; CHING-HUNG LIN; Toi M.; Wu J.; Lee S.-C. |
